• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚圣保罗医院千禧医学院唐氏综合征儿童的甲状腺异常。

Thyroid abnormalities in children with Down syndrome at St. Paul's hospital millennium medical college, Ethiopia.

机构信息

Department of Pediatrics, Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

出版信息

Endocrinol Diabetes Metab. 2022 May;5(3):e00337. doi: 10.1002/edm2.337. Epub 2022 Apr 14.

DOI:10.1002/edm2.337
PMID:35426257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9094469/
Abstract

BACKGROUND

Subclinical hypothyroidism (SCH) is the commonest thyroid abnormality in patients with Down syndrome (DS). The purpose of this study was to determine the prevalence and types of thyroid abnormalities, to assess the age at diagnosis, and to examine the screening practice in children with DS in a resource limited setting.

METHODOLOGY

A retrospective study was conducted in children with DS seen at endocrine follow-up clinic. Data were collected from patients' registration book and medical records.

RESULT

A total of 115 patients with DS were included in the study out of which 64 (59.8%) were males. Their median age at diagnosis was 9 months (range 4-15 years). Thyroid function test (TFT) was done at least once for 107 (93%) patients. Abnormal thyroid function was observed in 51 (47.7%) patients. The commonest thyroid abnormality was SCH (30/107, 28%) followed by congenital hypothyroidism (11/107, 10.3%), overt hypothyroidism (9/107, 8.4%) and hyperthyroidism (1/107, 0.9%). Most of the patients (86/107, 80.4%) were tested initially in the first 2 years of life. From those who were tested between the age of 2-6 months (n = 22 patients), seven (31.8%) patients had thyroid abnormalities.

CONCLUSION

Thyroid abnormalities were seen in a remarkable proportion of DS patients. The detection of abnormalities in the patients with age range of 2-6 months demands the need for additional TFT in this age category apart from the standard recommendation. Early diagnosis and management of thyroid abnormalities are important to decrease further impairment of cognition function in children with DS.

摘要

背景

亚临床甲状腺功能减退症(SCH)是唐氏综合征(DS)患者最常见的甲状腺异常。本研究旨在确定甲状腺异常的患病率和类型,评估诊断年龄,并检查资源有限环境中 DS 儿童的筛查实践。

方法

对内分泌随访诊所就诊的 DS 患儿进行回顾性研究。数据从患者登记册和病历中收集。

结果

共纳入 115 例 DS 患儿,其中 64 例(59.8%)为男性。他们的中位诊断年龄为 9 个月(范围 4-15 岁)。107 例(93%)患儿至少进行了一次甲状腺功能检查(TFT)。51 例(47.7%)患儿甲状腺功能异常。最常见的甲状腺异常是 SCH(30/107,28%),其次是先天性甲状腺功能减退症(11/107,10.3%)、显性甲状腺功能减退症(9/107,8.4%)和甲状腺功能亢进症(1/107,0.9%)。大多数患者(86/107,80.4%)在生命的头 2 年内首次接受检查。在 2-6 个月龄(n=22 例)接受检查的患者中,有 7 例(31.8%)存在甲状腺异常。

结论

DS 患儿甲状腺异常的比例相当高。在 2-6 个月龄的患者中发现异常,除了标准推荐外,还需要对该年龄段进行额外的 TFT 检查。早期诊断和管理甲状腺异常对降低 DS 患儿认知功能进一步受损非常重要。

相似文献

1
Thyroid abnormalities in children with Down syndrome at St. Paul's hospital millennium medical college, Ethiopia.埃塞俄比亚圣保罗医院千禧医学院唐氏综合征儿童的甲状腺异常。
Endocrinol Diabetes Metab. 2022 May;5(3):e00337. doi: 10.1002/edm2.337. Epub 2022 Apr 14.
2
Prospective study of thyroid function in the first year of life in infants with Down syndrome.唐氏综合征婴儿生命第一年甲状腺功能的前瞻性研究。
Eur J Pediatr. 2023 Jun;182(6):2903-2911. doi: 10.1007/s00431-023-04954-w. Epub 2023 Apr 15.
3
Prevalence of thyroid dysfunctions in infants and children with Down Syndrome (DS) and the effect of thyroxine treatment on linear growth and weight gain in treated subjects versus DS subjects with normal thyroid function: a controlled study.唐氏综合征(DS)患儿甲状腺功能障碍的患病率以及甲状腺素治疗对接受治疗的患儿与甲状腺功能正常的DS患儿线性生长和体重增加的影响:一项对照研究。
Acta Biomed. 2019 Sep 23;90(8-S):36-42. doi: 10.23750/abm.v90i8-S.8503.
4
Timing, prevalence, and dynamics of thyroid disorders in children and adolescents affected with Down syndrome.唐氏综合征患儿甲状腺疾病的发生时间、流行情况及动态变化。
J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):885-891. doi: 10.1515/jpem-2020-0119.
5
Evaluation of congenital heart diseases and thyroid abnormalities in children with Down syndrome.唐氏综合征患儿先天性心脏病和甲状腺异常的评估。
Anadolu Kardiyol Derg. 2010 Oct;10(5):440-5. doi: 10.5152/akd.2010.143.
6
Pattern, clinical presentations and management of thyroid diseases in national endocrine referral clinics, Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴提库尔安贝萨专科医院国家内分泌转诊诊所甲状腺疾病的模式、临床表现及管理
Ethiop Med J. 2012 Oct;50(4):287-95.
7
Subclinical Hypothyroidism as the Most Common Thyroid Dysfunction Status in Children With Down's Syndrome.唐氏综合征患儿最常见的甲状腺功能障碍状态为亚临床甲状腺功能减退症。
Front Endocrinol (Lausanne). 2022 Jan 4;12:782865. doi: 10.3389/fendo.2021.782865. eCollection 2021.
8
Thyroid Disorders in Subjects with Down Syndrome: An Update.唐氏综合征患者的甲状腺疾病:最新进展
Acta Biomed. 2018 Mar 27;89(1):132-139. doi: 10.23750/abm.v89i1.7120.
9
Thyroid dysfunction in a cohort of South African children with Down syndrome.南非唐氏综合征儿童队列中的甲状腺功能障碍。
S Afr Med J. 2013 Jul 29;103(12 Suppl 1):966-70. doi: 10.7196/samj.7111.
10
Thyroid disorders in Taiwanese children with Down syndrome: The experience of a single medical center.台湾唐氏症儿童的甲状腺疾病:单一医疗中心的经验。
J Formos Med Assoc. 2020 Jan;119(1 Pt 2):345-349. doi: 10.1016/j.jfma.2019.06.003. Epub 2019 Jun 27.

引用本文的文献

1
Autoimmune Thyroid Disease in Patients with Down Syndrome-Review.唐氏综合征患者的自身免疫性甲状腺疾病——综述
Int J Mol Sci. 2024 Dec 24;26(1):29. doi: 10.3390/ijms26010029.
2
Maternal Blood Group Is a Possible Predictor for Developing Congenital Heart Disease in Turkish Children with Down's Syndrome.母血型是土耳其唐氏综合征患儿患先天性心脏病的一个可能预测指标。
J Pediatr Genet. 2023 Sep 6;13(4):272-276. doi: 10.1055/s-0043-1774292. eCollection 2024 Dec.
3
Hypothyroidism in Patients with Down Syndrome: Prevalence and Association with Congenital Heart Defects.唐氏综合征患者的甲状腺功能减退症:患病率及其与先天性心脏病的关联。
Children (Basel). 2024 Apr 25;11(5):513. doi: 10.3390/children11050513.
4
Pediatric Population with Down Syndrome: Obesity and the Risk of Cardiovascular Disease and Their Assessment Using Omics Techniques-Review.唐氏综合征患儿群体:肥胖与心血管疾病风险及其组学技术评估——综述
Biomedicines. 2022 Dec 12;10(12):3219. doi: 10.3390/biomedicines10123219.

本文引用的文献

1
Hashimoto's Thyroiditis and Graves' Disease in Genetic Syndromes in Pediatric Age.儿童期遗传综合征中的桥本甲状腺炎和格雷夫斯病。
Genes (Basel). 2021 Feb 4;12(2):222. doi: 10.3390/genes12020222.
2
Prospective evaluation of autoimmune and non-autoimmune subclinical hypothyroidism in Down syndrome children.前瞻性评估唐氏综合征儿童的自身免疫和非自身免疫亚临床甲状腺功能减退症。
Eur J Endocrinol. 2020 Apr;182(4):385-392. doi: 10.1530/EJE-19-0823.
3
Phenotypic Expression of Autoimmunity in Children With Autoimmune Thyroid Disorders.自身免疫性甲状腺疾病患儿自身免疫的表型表达
Front Endocrinol (Lausanne). 2019 Jul 12;10:476. doi: 10.3389/fendo.2019.00476. eCollection 2019.
4
Congenital Cardiovascular Anomalies among Cases of Down Syndrome: A Hospital Based Review of Cases in TikurAnbessa Specialized Hospital, Ethiopia.唐氏综合征病例中的先天性心血管异常:基于埃塞俄比亚提库兰贝萨专科医院病例的医院回顾
Ethiop J Health Sci. 2019 Mar;29(2):165-174. doi: 10.4314/ejhs.v29i2.3.
5
Subclinical Hypothyroidism in Children: When a Replacement Hormonal Treatment Might Be Advisable.儿童亚临床甲状腺功能减退症:何时可能适合进行替代激素治疗。
Front Endocrinol (Lausanne). 2019 Feb 25;10:109. doi: 10.3389/fendo.2019.00109. eCollection 2019.
6
Thyroid function in Down syndrome.唐氏综合征中的甲状腺功能。
Expert Rev Endocrinol Metab. 2015 Sep;10(5):525-532. doi: 10.1586/17446651.2015.1063995. Epub 2015 Jul 1.
7
Thyroid Stimulating Hormone Level at Diagnosis as a Predictor of Persistent Subclinical Hypothyroidism in Children with Down Syndrome.唐氏综合征患儿诊断时的促甲状腺激素水平作为持续性亚临床甲状腺功能减退症的预测指标
Indian Pediatr. 2018 Jul 15;55(7):576-578.
8
Transient hypothyroidism in the newborn: to treat or not to treat.新生儿短暂性甲状腺功能减退症:治疗与否
Transl Pediatr. 2017 Oct;6(4):349-358. doi: 10.21037/tp.2017.09.07.
9
Endocrine manifestations of Down syndrome.唐氏综合征的内分泌表现。
Curr Opin Endocrinol Diabetes Obes. 2018 Feb;25(1):61-66. doi: 10.1097/MED.0000000000000382.
10
Characterization of Thyroid Abnormalities in a Large Cohort of Children with Down Syndrome
.一大群唐氏综合征患儿甲状腺异常的特征分析
Horm Res Paediatr. 2017;87(3):170-178. doi: 10.1159/000457952. Epub 2017 Mar 3.